Form 4: UnitedHealth Group Director John H. Noseworthy Acquires 300 Shares of Common Stock

Sentiment:

SEC Form 4


Director John H. Noseworthy purchased 300 shares of UnitedHealth Group (UNH) common stock at a price of $312.1563 on May 14, 2025, bringing his total direct holdings to 6,063 shares.

Summary

  • On May 14, 2025, John H. Noseworthy, a director of UnitedHealth Group (UNH), acquired 300 shares of the company's common stock.
  • The purchase price was $312.1563 per share.
  • The transaction increased Noseworthy's direct ownership to 6,063 shares of UNH common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a stock purchase by a director. While insider buying can be seen as a positive signal, it's a relatively small transaction and doesn't necessarily indicate a major shift in the company's outlook.

Positives

  • A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Insider buying is often monitored by investors as an indicator of management's sentiment regarding the company's prospects. It is a common practice for directors and officers to buy or sell shares of their own company.

Stakeholder Impact

  • The purchase could have a minor positive impact on shareholder sentiment.

Key Dates

DateDescription
05/14/2025Date of transaction: John H. Noseworthy purchased 300 shares of UNH common stock.
05/16/2025Date of signature: Faraz A. Choudhry, Attorney-in-Fact for John H. Noseworthy M.D., signed the form.

Keywords

UnitedHealth Group, UNH, Director, Stock Acquisition, John H. Noseworthy, Common Stock, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.